patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody drug conjugate
brentuximab vedotin
Phase 2updated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 18 investigational indications.
indications
indications
DLBCL
targets
TubulinTumor necrosis factor receptor superfamily member 8
all catalysts(1)
phase 1 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that